Table 1. Arrhythmia Vulnerability in mice treated with t-AUCB.

Groups	VT	AF
sham (n=5)	0	0
t-AUCB(5 mg/L)+ sham (n=5)	0	0
MI (n=10)	7(70%)*	3(30%)*
t-AUCB(0.2 mg/L) + MI (n=5)	3(60%)	1(20%)
t-AUCB(1 mg/L) + MI (n=5)	2(40%)#	1(20%)
t-AUCB(5 mg/L) + MI (n=8)	3(38%)#	2(25%)

VT, ventricular tachycardia; AF, atrial fibrillation. ^*P<0.05 vs. sham group; #P<0.05 vs. MI group.